<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-QBUMHPTR/acf672e9-a21d-4fe9-96a1-a93383da22df/PDF"><dcterms:extent>264 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-QBUMHPTR/e2d63a72-1d4c-4cb1-9ae3-a8db4dd48cac/TEXT"><dcterms:extent>12 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-QBUMHPTR"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>2000</dcterms:issued><dc:creator>Čufer, Tanja</dc:creator><dc:creator>Reberšek, Martina</dc:creator><dc:creator>Rudolf, Zvonimir</dc:creator><dc:creator>Serša, Gregor</dc:creator><dc:format xml:lang="sl">letnik:34</dc:format><dc:format xml:lang="sl">številka:4</dc:format><dc:format xml:lang="sl">str. 357-361</dc:format><dc:identifier>COBISSID:12586457</dc:identifier><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-QBUMHPTR</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Croatian Medical Association - Croatian Society of Radiology</dc:publisher><dc:publisher xml:lang="sl">Slovenian Medical Society - Section of Radiology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="sl">Breast neoplasms, male</dc:subject><dc:subject xml:lang="sl">Cisplatin</dc:subject><dc:subject xml:lang="sl">dojke</dc:subject><dc:subject xml:lang="sl">Drug delivery systems</dc:subject><dc:subject xml:lang="sl">Drug therapy</dc:subject><dc:subject xml:lang="sl">Electroporation</dc:subject><dc:subject xml:lang="sl">rak (medicina)</dc:subject><dc:subject xml:lang="sl">Therapy</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Electrochemotherapy with cisplatin of breast cancer tumor modules in a male patient|</dc:title><dc:description xml:lang="sl">Background. The metastases of breast cancer in a male patient were treated with electrochemotherapy by intratumoral injection of cisplatin. Electrochemotherapy is chemotherapy with the subsequent local application of electric pulses to the tumor nodules in order to increase drug delivery into the cells. Case report. Cutaneous metastases of breast cancer were treated with the intratumoral administration of cisplatin and by 8 electric pulses (1300 V/cm) applied a minute later to each cutaneous metastasis. The treatmentresulted in complete response of two electrochemotherapy treated cutaneous metastases and partial response of the third metastasis. In cutaneous metastases treated with intratumoral administartion of cisplatin without electric pulses, only partial response was obtained. Conclusion. This study confirms that electrochemotherapy with cisplatin is effective in the treatment of breast cancer metastases, too, as it was already proved for electrochemotherapy with bleomycin</dc:description><dc:description xml:lang="sl">Izvleček. Avtorji so zdravili kožne metastaze pri bolniku z rakom dojke z elektrokemoterapijo s cisplatinom. Elektrokemoterapija je zdravljenje s kemoterapijo, ki ji sledi lokalna aplikacija električnih pulzov na tumorske lezije; električni pulzi povečajo vnos kemoterapevtika v celice. Prikaz primera. Avtorji so zdravili kožne metastaze raka dojke z intratumorsko aplikacijo cisplatina in 8 električnimi pulzi, ki so jih na vsako kožno metastazo aplicirali 1 minuto po vnosu cisplatina. Pri zdravljenju z elektrokemoterapijo so pri dveh kožnih metastazah dosegli popolni odgovor, pri1 kožni metastazi pa delni odgovor. Pri kožnih metastazah, ki so jih zdravili samo z intratumorsko aplikacijo cispatina, pa so dosegli le delni odgovor. Zaključek. Elektrokemoterapija s cisplatinom je tako kot elektrokemoterapija z bleomicinom učinkovita pri zdravljenju kožnih metastaz raka na dojk</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-QBUMHPTR"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-QBUMHPTR" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-QBUMHPTR/acf672e9-a21d-4fe9-96a1-a93383da22df/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Onkološki inštitut Ljubljana</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-QBUMHPTR/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-QBUMHPTR" /></ore:Aggregation></rdf:RDF>